Log in to save to my catalogue

Closing the access barrier for effective anti-malarials in the private sector in rural Uganda: conso...

Closing the access barrier for effective anti-malarials in the private sector in rural Uganda: conso...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ccf735cd05ba4a768d77732d6f9dbc40

Closing the access barrier for effective anti-malarials in the private sector in rural Uganda: consortium for ACT private sector subsidy (CAPSS) pilot study

About this item

Full title

Closing the access barrier for effective anti-malarials in the private sector in rural Uganda: consortium for ACT private sector subsidy (CAPSS) pilot study

Publisher

England: BioMed Central Ltd

Journal title

Malaria journal, 2012-10, Vol.11 (1), p.356-356, Article 356

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Artemisinin-based combination therapy (ACT), the treatment of choice for uncomplicated falciparum malaria, is unaffordable and generally inaccessible in the private sector, the first port of call for most malaria treatment across rural Africa. Between August 2007 and May 2010, the Uganda Ministry of Health and the Medicines for Malaria Venture cond...

Alternative Titles

Full title

Closing the access barrier for effective anti-malarials in the private sector in rural Uganda: consortium for ACT private sector subsidy (CAPSS) pilot study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_ccf735cd05ba4a768d77732d6f9dbc40

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ccf735cd05ba4a768d77732d6f9dbc40

Other Identifiers

ISSN

1475-2875

E-ISSN

1475-2875

DOI

10.1186/1475-2875-11-356

How to access this item